메뉴 건너뛰기




Volumn 123, Issue 9, 2010, Pages 777-784

Practical considerations for planning a therapeutic apheresis procedure

Author keywords

Erythrocytapheresis; Leukapheresis; Plasmapheresis; Thrombocytapheresis

Indexed keywords

APHERESIS; AUTOIMMUNE DISEASE; BLOOD TRANSFUSION; EXTRACORPOREAL PHOTOPHERESIS; FLUID RESUSCITATION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOADSORPTION; INTERPERSONAL COMMUNICATION; KIDNEY DISEASE; LEUKAPHERESIS; LOW DENSITY LIPOPROTEIN APHERESIS; METABOLIC DISORDER; NEUROLOGIC DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; RED BLOOD CELL EXCHANGE; REVIEW; RISK FACTOR; THROMBOCYTOPHERESIS; TREATMENT INDICATION; TREATMENT PLANNING; VASCULAR ACCESS;

EID: 77956226557     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.01.022     Document Type: Review
Times cited : (36)

References (38)
  • 1
    • 34347394094 scopus 로고    scopus 로고
    • The new approach to assignment of ASFA categoriesintroduction to the fourth special issue: Clinical applications of therapeutic apheresis
    • Z.M. Szczepiorkowski, B.H. Shaz, N. Bandarenko, and J.L. Winters The new approach to assignment of ASFA categoriesintroduction to the fourth special issue: clinical applications of therapeutic apheresis J Clin Apher 22 2007 96 105
    • (2007) J Clin Apher , vol.22 , pp. 96-105
    • Szczepiorkowski, Z.M.1    Shaz, B.H.2    Bandarenko, N.3    Winters, J.L.4
  • 2
    • 34347408011 scopus 로고    scopus 로고
    • Guidelines on the use of therapeutic apheresis in clinical practice: Evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis
    • Z.M. Szczepiorkowski, N. Bandarenko, and H.C. Kim Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis J Clin Apher 22 2007 106 175
    • (2007) J Clin Apher , vol.22 , pp. 106-175
    • Szczepiorkowski, Z.M.1    Bandarenko, N.2    Kim, H.C.3
  • 3
    • 34347398426 scopus 로고    scopus 로고
    • Category IV indications for therapeutic apheresis: ASFA fourth special issue
    • B.H. Shaz, M.L. Linenberger, and N. Bandarenko Category IV indications for therapeutic apheresis: ASFA fourth special issue J Clin Apher 22 2007 176 180
    • (2007) J Clin Apher , vol.22 , pp. 176-180
    • Shaz, B.H.1    Linenberger, M.L.2    Bandarenko, N.3
  • 6
    • 0034073652 scopus 로고    scopus 로고
    • Therapeutic pediatric apheresis
    • H.C. Kim Therapeutic pediatric apheresis J Clin Apher 15 1-2 2000 129 157
    • (2000) J Clin Apher , vol.15 , Issue.12 , pp. 129-157
    • Kim, H.C.1
  • 7
    • 12844281677 scopus 로고    scopus 로고
    • Management of the therapeutic apheresis patient
    • H. Jones, and N. Bandarenko Management of the therapeutic apheresis patient B. McLeod, Apheresis, Principles and Practice 2nd edn. 2003 AABB Press Bethesda, MD 253 273
    • (2003) Apheresis, Principles and Practice , pp. 253-273
    • Jones, H.1    Bandarenko, N.2
  • 8
    • 0031668549 scopus 로고    scopus 로고
    • Frequency of immediate adverse effects associated with apheresis donation
    • B.C. McLeod, T.H. Price, and H. Owen Frequency of immediate adverse effects associated with apheresis donation Transfusion 38 1998 938 943
    • (1998) Transfusion , vol.38 , pp. 938-943
    • McLeod, B.C.1    Price, T.H.2    Owen, H.3
  • 9
    • 0028204002 scopus 로고
    • Complications of therapeutic plasma exchange: A recent assessment
    • D. Couriel, and R. Weinstein Complications of therapeutic plasma exchange: a recent assessment J Clin Apher 9 1994 1 5
    • (1994) J Clin Apher , vol.9 , pp. 1-5
    • Couriel, D.1    Weinstein, R.2
  • 10
    • 0024596277 scopus 로고
    • Risks and safety practices in hemapheresis procedures
    • D.W. Huestis Risks and safety practices in hemapheresis procedures Arch Pathol Lab Med 113 1989 273 278
    • (1989) Arch Pathol Lab Med , vol.113 , pp. 273-278
    • Huestis, D.W.1
  • 11
    • 0032966519 scopus 로고    scopus 로고
    • Frequency of immediate adverse effects associated with therapeutic apheresis
    • B.C. McLeod, I. Sniecinski, and D. Ciavarella Frequency of immediate adverse effects associated with therapeutic apheresis Transfusion 39 3 1999 282 288
    • (1999) Transfusion , vol.39 , Issue.3 , pp. 282-288
    • McLeod, B.C.1    Sniecinski, I.2    Ciavarella, D.3
  • 13
    • 0028241340 scopus 로고
    • Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality
    • D. Pittet, D. Tarara, and R.P. Wenzel Nosocomial bloodstream infection in critically ill patients Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
    • (1994) JAMA , vol.271 , pp. 1598-1601
    • Pittet, D.1    Tarara, D.2    Wenzel, R.P.3
  • 14
    • 84942476317 scopus 로고
    • The relationship between the thrombotic and infectious complications of central venous catheters
    • I.I. Raad, M. Luna, and S.A. Khalil The relationship between the thrombotic and infectious complications of central venous catheters JAMA 271 1994 1014 1016
    • (1994) JAMA , vol.271 , pp. 1014-1016
    • Raad, I.I.1    Luna, M.2    Khalil, S.A.3
  • 16
    • 0029058717 scopus 로고
    • Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers
    • T.M. Davis, B. Singh, and K.E. Choo Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers Br Heart J 73 1995 523 526
    • (1995) Br Heart J , vol.73 , pp. 523-526
    • Davis, T.M.1    Singh, B.2    Choo, K.E.3
  • 17
    • 0035110331 scopus 로고    scopus 로고
    • ECG abnormalities associated with hypocalcemia
    • B.M. RuDusky ECG abnormalities associated with hypocalcemia Chest 119 2001 668 669
    • (2001) Chest , vol.119 , pp. 668-669
    • Rudusky, B.M.1
  • 18
    • 0035670990 scopus 로고    scopus 로고
    • Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange
    • R. Weinstein Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange J Clin Apher 16 2001 210 211
    • (2001) J Clin Apher , vol.16 , pp. 210-211
    • Weinstein, R.1
  • 19
    • 27744464224 scopus 로고    scopus 로고
    • Current estimates of transfusion safety worldwide
    • R.Y. Dodd Current estimates of transfusion safety worldwide Dev Biol (Basel) 120 2005 3 10
    • (2005) Dev Biol (Basel) , vol.120 , pp. 3-10
    • Dodd, R.Y.1
  • 20
    • 0036690660 scopus 로고    scopus 로고
    • Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
    • R.Y. Dodd, E.Pt. Notari, and S.L. Stramer Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population Transfusion 42 2002 975 979
    • (2002) Transfusion , vol.42 , pp. 975-979
    • Dodd, R.Y.1    Notari, E.Pt.2    Stramer, S.L.3
  • 21
    • 0034934972 scopus 로고    scopus 로고
    • Non-infectious complications of transfusion therapy
    • P.L. Perrotta, and E.L. Snyder Non-infectious complications of transfusion therapy Blood Rev 15 2001 69 83
    • (2001) Blood Rev , vol.15 , pp. 69-83
    • Perrotta, P.L.1    Snyder, E.L.2
  • 22
    • 0037625865 scopus 로고    scopus 로고
    • Risks associated with transfusion of cellular blood components in Canada
    • S. Kleinman, P. Chan, and P. Robillard Risks associated with transfusion of cellular blood components in Canada Transfus Med Rev 17 2003 120 162
    • (2003) Transfus Med Rev , vol.17 , pp. 120-162
    • Kleinman, S.1    Chan, P.2    Robillard, P.3
  • 23
    • 0024209661 scopus 로고
    • Kinetics modeling of plasma exchange: Intra- and post-plasma exchange
    • R.M. Kellogg, and J.P. Hester Kinetics modeling of plasma exchange: intra- and post-plasma exchange J Clin Apher 4 1988 183 187
    • (1988) J Clin Apher , vol.4 , pp. 183-187
    • Kellogg, R.M.1    Hester, J.P.2
  • 24
    • 0034663327 scopus 로고    scopus 로고
    • How i treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
    • J.N. George How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Blood 96 2000 1223 1229
    • (2000) Blood , vol.96 , pp. 1223-1229
    • George, J.N.1
  • 25
    • 77956228523 scopus 로고    scopus 로고
    • Introduction to therapeutic apheresis: Principles, physiology, and patient management
    • AABB Press Bethesda, MD
    • Introduction to therapeutic apheresis: principles, physiology, and patient management B. McLeod, Therapeutic Apheresis: A Physician's Handbook 2005 AABB Press Bethesda, MD 1 32
    • (2005) Therapeutic Apheresis: A Physician's Handbook , pp. 1-32
    • McLeod, B.1
  • 26
    • 34249695002 scopus 로고    scopus 로고
    • Treatment of malaria in the United States: A systematic review
    • K.S. Griffith, L.S. Lewis, S. Mali, and M.E. Parise Treatment of malaria in the United States: a systematic review JAMA 297 2007 2264 2277
    • (2007) JAMA , vol.297 , pp. 2264-2277
    • Griffith, K.S.1    Lewis, L.S.2    Mali, S.3    Parise, M.E.4
  • 29
    • 0007654657 scopus 로고
    • Protein and biochemical changes during plasma exchange
    • M. Chopek, and J. McCullough Protein and biochemical changes during plasma exchange E.M. Berkman, J. Ulmas, Therapeutic Hemapheresis: A Technical Workshop 1980 American Association of Blood Banks Washington DC 13 52
    • (1980) Therapeutic Hemapheresis: A Technical Workshop , pp. 13-52
    • Chopek, M.1    McCullough, J.2
  • 30
    • 35848929491 scopus 로고    scopus 로고
    • Drug removal by plasmapheresis: An evidence-based review
    • R.B. Ibrahim, C. Liu, and S.M. Cronin Drug removal by plasmapheresis: an evidence-based review Pharmacotherapy 27 2007 1529 1549
    • (2007) Pharmacotherapy , vol.27 , pp. 1529-1549
    • Ibrahim, R.B.1    Liu, C.2    Cronin, S.M.3
  • 31
    • 0033909613 scopus 로고    scopus 로고
    • Clinical pharmacokinetics during plasma exchange
    • F. Fauvelle, O. Petitjean, M. Tod, and L. Guillevin Clinical pharmacokinetics during plasma exchange Therapie 55 2000 269 275
    • (2000) Therapie , vol.55 , pp. 269-275
    • Fauvelle, F.1    Petitjean, O.2    Tod, M.3    Guillevin, L.4
  • 32
    • 0346786557 scopus 로고    scopus 로고
    • Extracorporeal removal of antimicrobials during plasmapheresis
    • P.E. Kintzel, T. Eastlund, and K.A. Calis Extracorporeal removal of antimicrobials during plasmapheresis J Clin Apher 18 2003 194 205
    • (2003) J Clin Apher , vol.18 , pp. 194-205
    • Kintzel, P.E.1    Eastlund, T.2    Calis, K.A.3
  • 33
    • 35448944451 scopus 로고    scopus 로고
    • How we approach an apheresis request for a Category III, Category IV, or noncategorized indication
    • B.H. Shaz, J.L. Winters, N. Bandarenko, and Z.M. Szczepiorkowski How we approach an apheresis request for a Category III, Category IV, or noncategorized indication Transfusion 47 2007 1963 1971
    • (2007) Transfusion , vol.47 , pp. 1963-1971
    • Shaz, B.H.1    Winters, J.L.2    Bandarenko, N.3    Szczepiorkowski, Z.M.4
  • 34
    • 0036400058 scopus 로고    scopus 로고
    • An approach to evidence-based therapeutic apheresis
    • B.C. McLeod An approach to evidence-based therapeutic apheresis J Clin Apher 17 2002 124 132
    • (2002) J Clin Apher , vol.17 , pp. 124-132
    • McLeod, B.C.1
  • 35
    • 0028041172 scopus 로고
    • Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis
    • H.G. Owen, and M.E. Brecher Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis Transfusion 34 1994 891 894
    • (1994) Transfusion , vol.34 , pp. 891-894
    • Owen, H.G.1    Brecher, M.E.2
  • 36
    • 0035412623 scopus 로고    scopus 로고
    • Bradykinin production during donor plasmapheresis procedures
    • P. Perseghin, M. Capra, V. Baldini, and G. Sciorelli Bradykinin production during donor plasmapheresis procedures Vox Sang 81 2001 24 28
    • (2001) Vox Sang , vol.81 , pp. 24-28
    • Perseghin, P.1    Capra, M.2    Baldini, V.3    Sciorelli, G.4
  • 37
    • 0031261157 scopus 로고    scopus 로고
    • Cryofiltration apheresis and plasma fractionation causing anaphylactoid reactions in patients receiving angiotensin converting enzyme inhibitors
    • G.A. Siami, F.S. Siami, J.D. Morrow, and W.J. Stone Cryofiltration apheresis and plasma fractionation causing anaphylactoid reactions in patients receiving angiotensin converting enzyme inhibitors Ther Apher 1 1997 325 329
    • (1997) Ther Apher , vol.1 , pp. 325-329
    • Siami, G.A.1    Siami, F.S.2    Morrow, J.D.3    Stone, W.J.4
  • 38
    • 33644825243 scopus 로고    scopus 로고
    • Therapeutic apheresis in pediatric patients
    • R. Rogers, and L. Cooling Therapeutic apheresis in pediatric patients B. McLeod, Apheresis: Principles and Practice 2nd edn. 2005 AABB Press Bethesda, MD 477
    • (2005) Apheresis: Principles and Practice , pp. 477
    • Rogers, R.1    Cooling, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.